CXCL9 and neoplasm: Alternatively, Fitzgerald et al. demonstrated that increasing the intra-tumoral levels of CXCL9/10 in murine, KPC-derived PDAC tumors increased the recruitment of CXCR3+ NK and T cells and induced anti-tumor effects [12].